ALIMENTARY PHARMACOLOGY & THERAPEUTICS, cilt.38, sa.9, ss.1038-1044, 2013 (SCI-Expanded)
BackgroundCoffee consumption may modulate the risk of the metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD).